The FDA requires each establishment to register, submit and update a list of every HCT/P where collection, donor screening, donor testing, processing, storage, labeling, packaging, and distribution are performed. These requirements are described in 21 CFR 1271 Subpart B. Establishments must register and submit HCT/P lists using Form FDA 3356 which must be updated annually in December. Electronic registration also is available. Search for a registered HCT/P establishment using FDA's public query.
FDA to Host Virtual Town Hall on Gene Therapy Manufacturing
September 11, 2025
CMS to Join AABB eCast on Cellular Therapies Coding and Reimbursement
September 10, 2025
AABB Case Study Highlights CABP Credential’s Impact Across Biotherapies
September 10, 2025
4550 Montgomery Avenue
Suite 700, North Tower
Bethesda, MD 20814
301.907.6977
